DSM promises “business continuity” as it completes €436m omega-3 buy
date:Jul 21, 2012
It is DSMs fifth acquisition since it in 2010 announced its shift from being a fine chemicals player with a line in nutrients to a more focused life sciences company bring its total spend in the period to about has hit 1.7bn.

It also paid about 800m for Martek Biosciences in 2011 the largest algae-sourced omega supplier in the world. Both acquisitions are being housed in its new Nutritional Lipids division.

Board member Stephan Tanda previously told us Marteks infant food orientation and O
1/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/09 08:42